The overall objective of the Scleroderma Registry is to support and promote the basic science and clinical research of this complex rheumatic disease at the Hospital for Special Surgery (HSS). The registry facilitates our understanding of the clinical features, pathobiology, genetics of Scleroderma. This will ultimately lead to a potential treatment for this currently untreatable condition.
Scleroderma
The overall objective of the Scleroderma Registry is to support and promote the basic science and clinical research of this complex rheumatic disease at the Hospital for Special Surgery (HSS). The registry facilitates our understanding of the clinical features, pathobiology, genetics of Scleroderma. This will ultimately lead to a potential treatment for this currently untreatable condition.
Scleroderma Registry & Repository At the Hospital for Special Surgery
-
Hospital for Special Surgery, New York, New York, United States, 10021
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
For general information about clinical research, read Learn About Studies.
18 Years to
ALL
Yes
Hospital for Special Surgery, New York,
Robert F Spiera, MD, PRINCIPAL_INVESTIGATOR, Hospital for Special Surgery, New York
Jessica K Gordon, MD, PRINCIPAL_INVESTIGATOR, Hospital for Special Surgery, New York
2030-01